N-(3-Methoxyphenyl)-2-oxo-2-(2-((4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)acetamide

Catalog No. :
ACYYSK031
CAS No. :
765904-46-9
Molecular Formula :
C19H15N3O5
Molecular Weight :
365.35

IUPAC Name:(E)-N-(3-methoxyphenyl)-2-oxo-2-(2-((4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)acetamide

N-(3-Methoxyphenyl)-2-oxo-2-(2-((4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Methoxyphenyl)-2-oxo-2-(2-((4-oxo-4H-chromen-3-yl)methylene)hydrazinyl)acetamide
IUPAC Name(E)-N-(3-methoxyphenyl)-2-oxo-2-(2-((4-oxo-4H-chromen-3-yl)methylene)hydrazineyl)acetamide
MDL No.MFCD06199925
Molecular FormulaC19H15N3O5
Molecular Weight365.35
SMILESO=C(NC1=CC=CC(OC)=C1)C(N/N=C/C2=COC3=C(C=CC=C3)C2=O)=O
InChI KeyUVMSMQKUCXMQFI-KEBDBYFISA-N
SynonymSALOR-INT L492183-1EA;N-(3-MEO-PH)-2-OXO-2-(2-((4-OXO-4H-CHROMEN-3-YL)METHYLENE)HYDRAZINO)ACETAMIDE
CAS No.765904-46-9

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACYYSK031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTYLZ067 route compound structure diagram
    ACTYLZ06717422-74-1 In Stock
  4. Then
  5. ACYYSK031 route product structure diagram
    ACYYSK031765904-46-9
Inquiry

2. ACYYSK031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJXEI853 route compound structure diagram
    ACJXEI85327191-09-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYYSK031 route product structure diagram
    ACYYSK031765904-46-9
Inquiry

Comments (0)